Diffuse Large B‐Cell Lymphoma

This publication has 39 references indexed in Scilit:

• Rituximab therapy in malignant lymphoma
  Oncogene, 2007
• The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma
  Leukemia & Lymphoma, 2007
• CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell Lymphomas
  The American Journal of Surgical Pathology, 2000
• Anaplastic large‐cell lymphomas of B‐cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B‐cell lymphomas
  British Journal of Haematology, 2000
• Involvement ofBCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma
  Genes, Chromosomes and Cancer, 1998
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
  Blood, 1994
• Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
  Blood, 1994
• Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell Lymphoma
  Science, 1993
• Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region
  Blood, 1987
• Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant Lymphomas
  New England Journal of Medicine, 1987